NASDAQ · VRME

VerifyMe, Inc.

$0.65 +$0.01 (+1.39%) 1D After hours

Key Metrics

$8.41M
Market cap
P/E · TTM
$13.72M
Revenue · TTM
−$5.01M
Net income
EPS · TTM $-0.38
Dividend yield
Free cash flow
Beta · 1Y 1.66
EBITDA · TTM
Gross margin 42.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 18
    From its Jan 29 high, the share price fell 53%.

    Peak close $1.28 on Jan 29; trough close $0.60 on Jun 18. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -53%
  • Jun 1
    The stock moved +14.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 1
  • Mar 4
    The stock moved +22.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 4

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$8.41M
Enterprise value
Shares outstanding13.1M
52-wk range$0.59 – $1.51
Avg volume · 20D726.8K
Net cash
Book value / share$0.78
IndustryFinance Services
ExchangeNASDAQ
About VerifyMe, Inc.
IPO dateOct 23, 2001
Employees30

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.61
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 42.2%
Operating -37.0%
Net -36.6%
FCF
ROE / ROIC -48.7% · —

Financial Health

Current ratio3.94
Quick ratio3.92
Debt / equity
Debt / EBITDA
Net cash
Working capital$5.11M

Cash Flow · TTM

Operating CF $296.00K
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-7.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings